Effect of mannan oligosaccharides on growth performance of weanling pigs

• Published in: Journal of animal science 2003-10, Vol.81 (10), p.2482-2487
• Main Authors: LeMieux, F.M, Southern, L.L, Bidner, T.D
• Format: Article
• Language: English
• Subjects: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Anti-Bacterial Agents - pharmacology; antibiotics; diet; Drug Interactions; Eating - drug effects; Female; growth performance; Male; Mannans - pharmacology; Oligosaccharides; Random Allocation; swine; Swine - growth & development; swine feeding; Weaning; weanlings; Weight Gain - drug effects; zinc; Zinc - administration & dosage
• ISSN: 0021-8812; 1525-3163
• DOI: 10.2527/2003.81102482x

Four experiments were conducted to evaluate the effects of mannan oligosaccharides (provided by Bio-Mos [BM], a product containing a minimum of 28% glucomannoprotein from S. cerevisiae) on growth performance of nursery pigs. Treatments were replicated with five to six pens of four to five pigs each. Initial BW ranged from 4.7 to 5.4 kg, and pigs were weaned at 16 to 20 d of age. Experiments 1, 2, and 4 consisted of Phase 1 (7 to 8 d), Phase 2 (12 to 14 d), and Phase 3 (7 to 8 d) periods, but Exp. 3 consisted only of Phase 1 (7 d) and 2 (14 d) periods. The diets for Phase 1, 2, and 3 contained 1.6, 1.5, and 1.1% Lys, respectively. The treatments in Exp. 1 were 0, 0.20, and 0.30% BM, which did not affect growth performance. The treatments in Exp. 2 were two levels of excess Zn (0 and 3,000 ppm) and three levels of BM (0, 0.20, and 0.30%) in a 2 × 3 factorial. Excess Zn increased (P < 0.08) ADG and ADFI in Phase 2 and 3 and overall. The 0.20% BM addition increased ADG (Phase 3 and overall) and ADFI (Phase 2 and overall) in the absence of excess Zn but did not affect or decreased these response variables in the presence of excess Zn (Zn × BM quadratic, P < 0.08). Experiment 3 was similar to Exp. 2, but the 0.30% BM addition was not used. Excess Zn decreased (P < 0.09) ADG in Phase 1 but increased (P < 0.09) ADG and ADFI in Phase 2. The BM decreased (P < 0.03) overall ADFI but increased Phase 2 and overall ADG and gain:feed (GF) in the absence of excess Zn but not in the presence of excess Zn (Zn × BM, P < 0.07). The BM decreased ADFI during Phase 2, but the decrease was greater in pigs fed excess Zn (Zn × BM, P < 0.07). Experiment 4 evaluated the interactive effects of the antibiotic (oxytetracycline and neomycin) and BM and of Zn and BM. Antibiotic (no excess Zn) increased (P < 0.01) ADG and ADFI in Phases 2 and 3 and overall. The BM addition decreased ADG and GF in Phase 2 when the antibiotic was not in the diet but increased ADG when the antibiotic was in the diet (antibiotic × BM, P < 0.05). Excess Zn increased (P < 0.07) ADG and ADFI during Phases 2 and 3 and overall. In Phase 2, the 0.20% BM decreased GF when excess Zn was not added to the diet but increased GF when Zn was included (Zn × BM, P < 0.03). Mannan oligosaccharides improved pig performance in some instances during Phase 2 when fed in combination with an antibiotic and no excess dietary Zn, but it had no effect or negative effects in the presence of excess Zn or in the absence of an antibiotic.